A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity
- PMID: 21436470
- PMCID: PMC3260809
- DOI: 10.18632/oncotarget.244
A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity
Abstract
The p53 family transcription factors p53, p63 and p73 make diverse contributions in development and cancer. Mutation or deletion of p53 is observed in the majority of human cancers. In contrast, p63 and p73 are not lost in cancer but mediate distinct genetic roles in normal and tumor-specific contexts: p73 promotes genome stability and mediates chemosensitivity, while p63 largely lacks these p53-like functions and instead promotes proliferation and cell survival. We recently uncovered a mechanism which maintains p63/p73 homeostasis within the epithelium through direct transcriptional regulation of microRNAs (miRs). We discovered that several of the top p63-regulated miRs target p73 for inhibition, including miR-193a-5p, a direct p63/p73 transcriptional target which is repressed by p63 and activated by p73 both in vitro and in vivo. The resulting feed-forward circuit involving p63, miR-193a-5p and p73 controls p73 levels, cell viability and DNA damage susceptibility in certain cancers including squamous cell carcinoma. Here, we discuss the evolutionary implications of this regulatory circuit, which may point to a general mechanism of miR-mediated cross-talk within transcription factor gene families. Additionally, we suggest that inducible chemoresistance mediated by this miR-dependent mechanism might be an attractive target for therapeutic intervention.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures

Similar articles
-
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.J Clin Invest. 2011 Feb;121(2):809-20. doi: 10.1172/JCI43897. J Clin Invest. 2011. PMID: 21293058 Free PMC article.
-
The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex.PLoS One. 2010 May 12;5(5):e10615. doi: 10.1371/journal.pone.0010615. PLoS One. 2010. PMID: 20485546 Free PMC article.
-
The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.Cancer Metastasis Rev. 2010 Dec;29(4):613-39. doi: 10.1007/s10555-010-9257-9. Cancer Metastasis Rev. 2010. PMID: 20922462 Review.
-
p63 and p73: roles in development and tumor formation.Mol Cancer Res. 2004 Jul;2(7):371-86. Mol Cancer Res. 2004. PMID: 15280445 Review.
-
The p53/p63/p73 family of transcription factors: overlapping and distinct functions.J Cell Sci. 2000 May;113 ( Pt 10):1661-70. doi: 10.1242/jcs.113.10.1661. J Cell Sci. 2000. PMID: 10769197 Review.
Cited by
-
The microRNA feedback regulation of p63 in cancer progression.Oncotarget. 2015 Apr 20;6(11):8434-53. doi: 10.18632/oncotarget.3020. Oncotarget. 2015. PMID: 25726529 Free PMC article. Review.
-
Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death.Carcinogenesis. 2015 Jun;36 Suppl 1(Suppl 1):S89-110. doi: 10.1093/carcin/bgv032. Carcinogenesis. 2015. PMID: 26106145 Free PMC article. Review.
-
Mechanisms, function and clinical applications of DNp73.Cell Cycle. 2013 Jun 15;12(12):1861-7. doi: 10.4161/cc.24967. Epub 2013 Jun 13. Cell Cycle. 2013. PMID: 23708520 Free PMC article. Review.
-
Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.Biomaterials. 2019 Oct;218:119342. doi: 10.1016/j.biomaterials.2019.119342. Epub 2019 Jul 12. Biomaterials. 2019. PMID: 31326657 Free PMC article.
-
TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth.Oncotarget. 2013 Nov;4(11):1894-903. doi: 10.18632/oncotarget.1228. Oncotarget. 2013. PMID: 24177167 Free PMC article.
References
-
- Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell. 2009;137:413–431. - PubMed
-
- Moll UM, Slade N. p63 and p73: roles in development and tumor formation. Mol Cancer Res. 2004;2:371–386. - PubMed
-
- DeYoung MP, Ellisen LW. p63 and p73 in human cancer: defining the network. Oncogene. 2007;26:5169–5183. - PubMed
-
- Yang A, Kaghad M, Caput D, McKeon F. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet. 2002;18:90–95. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous